Hemophilia A (Factor VIII) Inversions

10400
4.8
NABL, CAP, ISO
ADD TO CART

What is Hemophilia A (Factor VIII) Inversions?

The deficiency of clotting factor VIII is the main cause of the condition Hemophilia A. It is a rare condition that affects only about 0.02% of males. The major symptom in males is excessive bleeding. Females do not experience bleeding but are at a risk of delivering affected offspring. The test detects intron 22 inversion with F8 gene.

Sample Type

The sample type collected for Hemophilia A (Factor VIII) Inversions is: Blood

Preparation for Hemophilia A (Factor VIII) Inversions

  • No special preparation required

Why Get Tested for Hemophilia A (Factor VIII) Inversions?

This test is ideal for males affected with severe hemophIlia, who have been previously identified with a familial intron 22 inversion. The test is useful for first tier molecular testing. Women with a family history of severe haemophilia A must also get tested.


Provided By

NABL

CAP

ISO

We focus on providing patients quality diagnostic healthcare services in India. Through our network, we offer patients convenient locations for their diagnostic healthcare services and efficient service. With over 3368 diagnostic and related healthcare tests and services offered, we believe we are capable of performing substantially all of the diagnostic healthcare tests and services currently prescribed by physicians in India. Our key competitive strengths are: Business model focused on the patient as a customer and an established consumer healthcare brand associated with quality services, in a market where patients generally choose their diagnostic healthcare service provider. Well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry. A network whose growth yields greater economies of scale, combined with a hub and spoke model that is scalable for further growth. Centralized information technology platform that fully integrates our network and is scalable. Attractive financial performance, financial profile and return on invested capital. Experienced leadership team with strong industry expertise and successful track record. Some of our laboratories have achieved International Organization for Standardization, or ISO, certification for their quality systems. Our National Reference Laboratory has obtained ISO 9001:2008 certification (for the performance of routine and advanced diagnostic pathology testing services, including clinical trials), ISO 15189:2007 (for quality management in medical laboratories), ISO 15189:2012 certification (in the field of medical testing) and ISO 27001:2013 certification (for establishing an effective information management system that maintains and processes information security at our data center).